SCHEMBL20067042

SCHEMBL20067042

COC(=O)CCN(CCNC(=O)CCN(CCCl)CCC(=O)NCCN(CCC(=O)OC)CCC(=O)OC)CCC(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 5/20 0.38
RECQL P46063 1/20 0.37
FAAH O00519 2/20 0.37
DNM1 Q05193 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP3A4 P08684 1/20 0.34
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ABCB11 O95342 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GSR P00390 1/20 0.33
HTT P42858 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
EPHX2 P34913 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22414250 0.95 TSHR (0.40) MEN1KMT2ATSHRRECQLFAAH
SCHEMBL12423819 0.90 KMT2A (0.47) MEN1KMT2ATSHRRECQLFAAH
SCHEMBL22414251 0.89 FAAH (0.40) MEN1KMT2ATSHRRECQLFAAH
SCHEMBL20067044 0.87 MEN1 (0.37) MEN1KMT2ATSHRRECQLFAAH
SCHEMBL10598283 0.86 KMT2A (0.54) MEN1KMT2ATSHRCA12CA14
SCHEMBL19035553 0.85 CYP1A2 (0.44) MEN1KMT2ATSHRRECQLDNM1
SCHEMBL18174866 0.85 KMT2A (0.43) MEN1KMT2ATSHRRECQLDNM1
SCHEMBL20067053 0.84 MEN1 (0.40) MEN1KMT2ATSHRRECQLDNM1
Hydrochloric Acid SCHEMBL10494484 0.84 KMT2A (0.57) MEN1KMT2ATSHRCA12CA14
SCHEMBL12461822 0.83 RECQL (0.52) MEN1KMT2ATSHRRECQLFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10707524-B2 Graphene compound and manufacturing method thereof, electrolyte, and power storage device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-07-07 US disclosed
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 US disclosed
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10707524-B2 Graphene compound and manufacturing method thereof, electrolyte, and power storage device ILK, GK, KCNH3 MEN1 4232/4885KMT2A 1311/4885TSHR 3831/4885
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE ILK, GK, KCNH3 MEN1 4232/4885KMT2A 1311/4885TSHR 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.